Scientific Rationale for a Bottom-Up Approach to Target the Host Response in Order to Try and Reduce the Numbers Presenting With Adult Respiratory Distress Syndrome Associated With COVID-19. Is There a Role for Statins and COX-2 Inhibitors in the Prevention and Early Treatment of the Disease?
The inflammatory response to and the subsequent development of Adult Respiratory Distress Syndrome (ARDS) is considered to underpin COVID-19 pathogenesis. With a developing world catastrophe, we need to examine our known therapeutic stocks, to assess suitability for prevention and/or treatment of th...
Main Author: | Geoffrey Mark Verrall |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-09-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2020.02167/full |
Similar Items
-
The effect of statins on the prevalence and mortality of influenza virus infection: a systematic review and meta-analysis
by: Amir Vahedian-Azimi, et al.
Published: (2022-11-01) -
Development and Challenges of Diclofenac-Based Novel Therapeutics: Targeting Cancer and Complex Diseases
by: Ayeman Amanullah, et al.
Published: (2022-09-01) -
LIPID DISTRESS-SYNDROME AND PROSPECTS OF ITS CORRECTION BY STATINES
by: Tatiana Denisyuk, et al.
Published: (2017-09-01) -
Safety of statins
by: Debasish Maji, et al.
Published: (2013-01-01) -
Efficacy and safety of alirocumab in patients with hypercholesterolemia not adequately controlled with non-statin lipid-lowering therapy or the lowest strength of statin: ODYSSEY NIPPON study design and rationale
by: Tamio Teramoto, et al.
Published: (2017-06-01)